The 45th session of the Awards recognizes COVID 19 vaccine developers, nanotechnology scientists, and prominent figures in the categories of Arabic Language and Literature, Islamic Studies, and Service to Islam.
Professor Jacky Il Ying
Professor Sarah Gilbert
JEDDAH, Saudi Arabia, Jan. 4, 2023 (GLOBE NEWSWIRE) — Two female scientists have been announced as recipients of the 2023 King Faisal Prize for Medical Sciences. Covid-19 vaccine developer and nanotechnology scientist. Her six others were awarded the King Faisal Award for enriching mankind with important and valuable achievements and discoveries in the fields of medicine, science, Arabic language and literature, Islamic studies and service to Islam. announced as a person.
The women behind Oxford and AstraZeneca’s COVID-19 vaccine, Professor Sarah GilbertSaid, Chair of the Department of Vaccines at the University of Oxford’s Nuffield School of Medicine, has been named a King Faisal Prize in Medicine winner. She co-created the vaccine. This vaccine is used in more than 180 countries, saving billions of lives due to its efficiency, low cost and accessibility.
This vaccine, called ‘ChAdOx1 nCoV-19’, was achieved in 10 months of work using a new approach. Instead of traditional vaccine methods, which use weakened or killed forms of the original infection and require a long time to develop in humans, Gilbert developed a weakened version of the common virus that causes the common cold in chimpanzees. was genetically modified and injected. without infecting humans. This modified virus became the essence of a vaccine developed by Dr. Gilbert against coronaviruses that carry the genetic instructions of the coronavirus spike protein. produce specific surface spike proteins of coronaviruses, trigger an immune response, and prime the immune system to attack coronaviruses if they infect the body.
Dr Gilbert’s innovative vaccine technology, recently used against COVID-19, has also been applied by her to malaria, Ebola, influenza and MERS, the latter in clinical trials in the UK and the Kingdom of Saudi Arabia. She also worked on developing a drug against it. In fact, her patented ChAdOx1 technology was developed in her 2012 by her Dr. Gilbert and other researchers at the University of Oxford. In 2014, she led the first trials of her Ebola vaccine after the Ebola outbreak in West Africa. It is thanks to ChAdOx1 technology and her accumulated research that her COVID-19 vaccine for Oxford and AstraZeneca was manufactured so quickly.
Another female scientist selected for the King Faisal Prize for Science Professor Jacky Il Ying; A*STAR Senior Researcher and Director, Nano-Bio Research Institute, Research Institute of Science and Technology. She was selected for her work on the synthesis of various advanced nanomaterials and systems and their applications in catalysis, energy conversion and biomedical. Her inventions have been used to solve problems in various fields of medicine, chemistry and energy. Her development of stimuli-responsive polymer nanoparticles has led to a technology that can autoregulate insulin release in response to blood glucose levels in diabetic patients without the need for external blood glucose monitoring. Dr. Ying’s lab pioneered the synthesis of mesoporous and microporous transition metal oxides. A class of nanomaterials used for energy storage and conversion through supramolecular templating (organization or assembly of entities).
Dr. Ying has over 180 major patents and patent applications. 32 of them are licensed to multinationals and start-ups for a variety of applications including nanomedicine, drug delivery, cell and tissue engineering, medical implants, biosensors and medical devices. Her work lies at the intersection of nanotechnology and technical medicine, leading to the founding of her six successful start-ups and spin-off companies.
In 2023, two other medical science award winners have been selected. Professor Dan BaluchDirector of the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, William Bosworth Castle, Professor of Medicine, Harvard Medical School, and Professor Chad MirkinDirector of the International Institute of Nanotechnology (IIN), Rathman Professor of Chemistry, and Professor of Medicine, Materials Science and Engineering, Biomedical Engineering, and Chemical and Biotechnology at Northwestern University, respectively.
Professor Dan Barouch has developed another COVID-19 viral vector vaccine. Johnson & Johnson’s vaccine using the same technology as Oxford AstraZeneca’s COVID-19 vaccine. Administered to hundreds of millions of people worldwide, saving lives. The vaccine, like his Oxford He vaccine, is delivered in as short a time as 13 months and contains a harmless adenovirus (called Ad26), a common type of virus that causes mild cold symptoms when it infects humans. ) was based on the design of A genetically engineered virus carries the genetic code for the coronavirus spike protein. After injection with adenovirus, the cells use the genetic code to produce spike proteins to train the immune system and create antibodies and memory cells to protect against COVID-19 infection.
The development of the Ad26 vaccine platform is the result of research work and clinical trials to develop vaccine candidates against multiple pathogens of global importance, including HIV, Zika virus and tuberculosis, and Professor Barouch has created a series of vaccine platforms. has become a pioneer in Technologies that can be used in developing vaccines for emerging infectious diseases such as COVID-19. In addition, he led the world’s first demonstration of Zika his vaccine protection in preclinical studies and initiated a series of Phase 1 Zika vaccine clinical trials.
At the forefront of nanochemistry for over 30 years, Professor Chad Mirkin’s work helped define the modern era of nanotechnology. He is best known for his invention of Spherical Nucleic Acid (SNA). SNAs are nanostructures composed of spherical nucleic acids that can enter human cells and tissues, overcome biological barriers, and enable the detection and treatment of diseases at the genetic level. More than 1,800 of his products for medical diagnosis, therapy and life science research are based on this technology.
Professor Markin is a pioneer in the field of materials discovery based on artificial intelligence. He dipped his pen invented his nanolithography. This is what National Geographic described as one of his “top 100 scientific discoveries that changed the world.” HARP (Large Area Rapid Printing) technology is a 3D printing process that can produce a variety of products, including ceramics, at record-breaking throughput.
In addition to medicine and science, the King Faisal Prize this year recognizes outstanding thinkers and scholars in the fields of Arabic language and literature, Islamic studies, and their pivotal role in serving Islam, Muslims, and humanity. Honoring exemplary leaders. big.
Prof. Abdelfatta Kirito The winners of the ‘Arabic Language and Literature’ award, which focuses on ‘classical Arabic stories and contemporary theories’, have been announced. He has been a visiting professor and lecturer at the New He Sorbonne, Harvard, Princeton, Chicago, Oxford and College de France. Professor Robert HillenbrandEmeritus Professor Fellow of the Department of Islamic and Middle Eastern Studies (IMES) at the University of Edinburgh has been selected to receive the ‘Islamic Studies’ award for ‘Islamic Architecture’. His work covered North Africa, Egypt, Palestine and Central Asia, and was distinguished by its geographical and temporal extension from early Islamic times to his 19th century.
As for the Service to Islam Award, Professor Choi Yong Kilhamed and His Excellency Sheikh Nasser bin Abdullah Al-Zahbi were this year’s recipients.
Since 1979, the King Faisal Prize has recognized 290 laureates in five different categories for outstanding contributions to a variety of sciences and purposes. Each winner will receive her US$200,000. A 24 carat gold medal weighing 200 grams and a certificate engraved with the names of the winners and a summary of their work to qualify for the award.
CONTACT: Maysa Shawwa King Faisal Prize Maysa.Shawwa@kff.com